Skip to main content
Caplight Logo









AIBODY

AIBODY

Private
LondonHealthcare & Life Scienceshttps://aibody.io/

Last Round

Seed

Mar 18, 2021

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AIBODY is a healthcare technology company that provides a cloud-based digital physiology platform for medical education, clinical training, and research through high-fidelity human body simulations.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Synthetic Data, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

physiological simulationvirtual patientdigital twinmedical simulationclinical trainingsynthetic datapharmacological simulationmedical educationdrug discoveryhealthcare analyticsSaaSB2B healthcarevirtual clinical trialsin silico medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AIBODY Comparables

Compare AIBODY with similar companies based on industry and business-model similarity.

AIBODY comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HC Simulation, LLC
82%
Mantis Biotechnology
78%
Computational Life
78%

AIBODY Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 18, 2021

Key People

Founding team and executive leadership

Oleksandr Mokin

Chief Technology Officer

Executive Team

AIBODY Investors

Notable investors and investment history

AIBODY investors
InvestorRounds
Raw VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 41% MoM, reaching 2.6K.

  • Jun 1, 2025

    Monthly visitors increased 53% MoM, reaching 2.9K.

AIBODY Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AIBODY Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AIBODY's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range28
Year Founded2020
Last FundingMar 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?